Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: A prospective cohort study

Rheumatology International

Volumn 26, Issue 6, 2006, Pages 500-509

  Stockman, A ^a   Tait, B D ^a   Wolfe, R ^b   Brand, C A ^a   Rowley, M J ^c   Varney, M D ^a   Buchbinder, R ^c   Muirden, K D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLGLUTAMYLARGINYLALANYLALANINE; BIOLOGICAL MARKER; EPITOPE; GENE PRODUCT; HLA DR ANTIGEN; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; AREA UNDER THE CURVE; ARTHRITIS; ARTICLE; COHORT ANALYSIS; COMMUNITY BASED REHABILITATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; EROSION; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; GENETIC MARKER; GROUPS BY AGE; HAND RADIOGRAPHY; HUMAN; INFLAMMATORY ARTHRITIS; JOINT SWELLING; LABORATORY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN MOTIF; REMISSION; RHEUMATOID ARTHRITIS; RISK; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; X RAY;

AGE OF ONSET; ARTHRITIS; COHORT STUDIES; EPITOPES; FEMALE; FOLLOW-UP STUDIES; FOOT; GENETIC MARKERS; HAND; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; RHEUMATOID FACTOR; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33645342489     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0027-x     Document Type: Article

References (49)

1. Van der Heijde DMFM, van Riel PLCM, van Rijswijk MH, van de Putte LBA (1988) Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 17:284-292
2. Young A, Corbett M, Winfield J, Jaqueremada D, Williams P, Papasavvas G, Hay F, Roitt I (1988) A prognostic index for erosive changes in hands, feet and cervical spine in early rheumatoid arthritis. Br J Rheumatol 27:94-101
3. Harrison B, Symmons D (2000) Early inflammatory polyarthritis: result from Norfolk arthritis register with a review of literature. II. Outcome at three years. Rheumatology 39:939-949
4. Landewe RBM, Boers M, Verhoeven AC, Westhovens R, van de Laar MAFJ, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BAC, Jacobs P, Boonen A, van der Heijde DMFM, van der Linden S (2002) Cobra combination therapy in patients with early rheumatoid arthritis. Long-term structural benefits of a brief intervention. Arthritis Rheum 46:347-356
5. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 22:2208-2213
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
7. Nissilä M, Isomäki H, Kaarela K, Kiviniemi P, Martio J, Sarna S (1983) Prognosis of inflammatory joint diseases. Scan J Rheumatol 12:33-38
8. Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA (1993) The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 20:2005-2009
9. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW (2002) How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357-365
10. Harrison BJ, Symmons DPM, Barrett EM, Silman AJ (1998) The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 25:2324-2330
11. Gorman JD, Lum RF, Chen JJ, Suarez-Amazor ME,Thomson G, Criswell LA (2004) Impact of shared epitope genotype and ethnicity on erosive arthritis. A meta-analysis of 3240 rheumatoid arthritis patients. Arthritis Rheum 50:400-412
12. Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, Barrett E, Silman A (1999) The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 42:2174-2183
13. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, Birley A, Emery P (1994) Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 37:1166-1170
14. El-Gabalawy HS, Goldbach-Mansky R, Smith D, II, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR, Jr (1999) Association of HLA Alleles and the clinical features in the patients with synovitis of recent onset. Arthritis Rheum 42:1696-1705
15. Lard LR, Boers M, Verhoeven A, Vos K, Visser H, Hazes JMW, Zwinderman AH, Schreuder GMT, Breedveld FE, de Vries RRP, van der Linden S, Zanelli E, Huizinga TWJ (2002) Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum 46:899-905
16. De Vries N, Tijssen H, van Riel PLCM, van de Putte LBA (2002) Reshaping the shared epitope hypothesis. HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum 46:921-928
17. Tuokko J, Nejenstev S, Luukkainen R, Toivanen A, Ilonen J (2001) HLA Haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum 44:315-322
18. Mattey DL, Hassell AB, Plant MJ, Cheung NT, Dawes PT, Jones PW, Thomson W, Poulton KV, Hajeer AH, Ollier WER (1999) The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis. Rheumatology 38:1221-1227
19. Wagner U, Kaltenhäuser S, Pierer M, Seidel W, Troltzsch M, Häntzschel H, Kalden JR, Wassmuth R (2003) Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology 42:553-562
20. Bukhari M, Lunt M, Harrison BJ, Scott DGI, Symmons DPM, Silman AJ (2002) Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Arthritis Rheum 46:906-912
21. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393-406
22. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213
23. Larsen A, Dale K, Eek (1976) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481-491
24. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria for rheumatoid arthritis. JAMA 140:659-662
25. Pincus T, Summey JA, Soraci Jr SA,Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346-1353
26. Pinals RS, Masi AT, Larsen RA, and the subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308-1315
27. StataCorp (1999) Stata Statistical Software: Release 6.0. College Station, TX, US. Stata Corporation
28. Hulsmans HMJ, Jacobs JWG, van der Heijde DMFM, van Albada-Kuipers GA, Schenk Y, Bijlsma JWJ (2000) The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum 43:1927-1940
29. Weyand CM, Hicok KC, Conn DL, Goronzy JJ (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Int Med 117:801-806
30. Machold KP, Stamm TA, Eberl GJM, Nell VKP, Dunky A, Uffmann M, Smolen JS (2002) Very recent onset arthritis-clinical, laboratory and radiological findings during the first year of disease. J Rheumatol 29:2278-2287
31. Patatantian E, Thompson DF (2002) A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy 22:1157-1162
32. Woolf AD, Hall ND, Goulding NJ, Kantharia B, Maymo J, Evison G, Maddison PJ (1991) Predictors of the long-term outcome of early synovitis: a 5- year follow-up study. Br J Rheumatol 30:251-254
33. Eberhardt K, Fex E (1998) Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years. Br J Rheumatol 37:1324-1329
34. Pease CT, Bhakta BB, Devlin J, Emery P (1999) Does age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors. Rheumatology 38:228-234
35. Thomson W, Harrison, Ollier B, Wiles N, Payton T, Barrett J, Symmons D, Silman A (1999) Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis. Arthritis Rheum 42:757-762
36. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, Bruce B (2002) HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort. Arthritis Rheum 46:2320-2329
37. Feigenbaum SL, Masi AT, Kaplan SB (1979) Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 66:377-384
38. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, Meyer O, Sany J, J-P Daures, Dubois A (2001) Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 44:1736-1743
39. van der Heijde DMFM, van Leeuwen MA, van Kiel PLCM, Koster AM, van't Hof MA, van Rijswijk MH, van de Putte LBA (1992) Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 35:26-34
40. van Leeuwen MA, van Rijswijk MH, Sluiter WJ, van Riel PLCM, Kuper IH, van de Putte LBA, Pepys MB, Limburg PC (1997) Individual relationship between progression of radiological damage and acute phase response in early rheumatoid arthritis. Towards development of decision support system. J Rheumatol 24:20-27
41. Aho K, Heliovaara M, Maatela J, Toumi T, Palosuo T (1999) Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 18:1282-1284
42. Benoist C, Mathis D (2000) A revival of B cell paradigm for rheumatoid arthritis pathogenesis. Arthritis Res 2:90-94
43. Rau R, Herborn G, Menninger H, Sangha O (2002) Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology 41:196-204
44. van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ (1995) Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 38:1466-1474
45. Van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, Houtman PM, van Riel PLCM, van de Putte LBA, Limburg PC (1994) Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts and acute phase reactants. J Rheumatol 21:425-429
46. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes REM, Huizinga TWJ (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis. A prospective cohort study. Arthritis Rheum 50:709-715
47. Molenaar ETH, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans AC (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 50:36-42
48. Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A (2002) Stromelsyin 1 (Matrix Metalloproteinase 3) and HLA-DRB1 gene polymorphisms. Arthritis Rheum 46:1754-1762
49. Cook AD, Stockman A, Brand CA, Tait BD, Mackay IR, Muirden KD, Bernard CCA, Rowley MJ (1999) Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum 42:2569-2576